4//SEC Filing
Reine Allan 4
Accession 0000899243-21-003967
CIK 0001822462other
Filed
Jan 31, 7:00 PM ET
Accepted
Feb 1, 9:26 PM ET
Size
5.5 KB
Accession
0000899243-21-003967
Insider Transaction Report
Form 4
Reine Allan
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-01-28+120,000→ 120,000 totalExercise: $16.63Exp: 2031-01-27→ Common Stock (120,000 underlying)
Footnotes (1)
- [F1]The options will vest as to 25% of the underlying shares of common stock on January 28, 2022, the first anniversary of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option is fully vested.
Documents
Issuer
Foghorn Therapeutics Inc.
CIK 0001822462
Entity typeother
Related Parties
1- filerCIK 0001714023
Filing Metadata
- Form type
- 4
- Filed
- Jan 31, 7:00 PM ET
- Accepted
- Feb 1, 9:26 PM ET
- Size
- 5.5 KB